Amneal Pharmaceuticals
AMRX----
Amneal Pharmaceuticals (AMRX)
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and speci...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Amneal Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$18.754.63%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- MorningStar · 2 days ago, 12:44 PM
Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm
- ZeroHedge · Jul 22 at 08:45 AM
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
- rttnews · Jul 19 at 12:05 PM
5 Undervalued Stocks That Soared: SION +277%, FBRX +306%, NKTR +869% & More
- PUBT · Jul 17 at 07:02 AM
Amneal wins FDA approval for additional iohexol injection strengths and vial sizes
- PUBT · Jul 9 at 03:05 PM
Amneal Pharmaceuticals to report second-quarter 2026 results, host webcast
- PUBT · Jul 8 at 03:14 PM
Amneal, Adalvo win FDA review acceptance for generic tirzepatide autoinjector ANDAs
